1Valdezate S, Vindel A, Loza E, et al. Topoisomerase Ⅱ and Ⅳ quinolone resistance- determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility [J]. Antimicrob Agents Chemother,2002,46(3) : 665. 被引量：1
2Valdezate S, Vindel A, Echeita A. et al. Antimicrobial susceptibilities of unique Stenotrophomonas maltophilia clinical strains [J]. Antimicrob Agents Chemother, 2001,45(5) : 1581. 被引量：1
3Pan F F, Jin Y H, Ma J H, et al. Clinical analysis and antimicrobial susceptibility of nosocomial stenotrophomon as maltophilia [J]. Chin J Nosocom, 2001,11 (6) ; 409. 被引量：1
4Wang B Q, Hu B J, He L X. Stenotrophomonas maltophilia with multiple antimicrobial resistance in hospital[J]. Chin J Nosocom ,1999,9(4) :252. 被引量：1
5Yang L J, Lin G Q, Wang S L, et al. Clinical predisposition and antimicrobial resistance of Stenotrophomonas maltophilia [J]. Chin J Nosocom, 1999,9(3) : 140. 被引量：1
6Lin L M, Chen R, Xiang M J. Analysis of clinical characteristics and antimicrobial resistence of Stenotrophomonas maltophilia [J]. Chin J Nosocom, 2000, 10(Suppl) : 282. 被引量：1
7Aloson A, Jose M L. Multiple antibiotic resistance in Stenotrophornonas rnaltophilia [J]. Antirnicrob Agents Chemother, 1997,41 (5) : 1140. 被引量：1
8Zhang L, Li X Z, Poole K. SmeDEF multidrug efflux pump contributes to intrinsic multidrug resistance in Stenotrophomonas maltophilia [J]. Antimicrob Agents Chemother,2001,45(12 ) :3497. 被引量：1
9Zhang L, Li X Z, Poole K. SmeC, a outer membrane multidrug efflux protein of Stenotrophomonas maltophilia[J]. Antimicrob Agents Chemother , 2002,2 : 333. 被引量：1
10Avison M B, Higgins C S, Ford P J. Differential regulation of L1 and L2 beta-lactamase expression in Stenotrophomonas maltophilia [J]. J Antilnicrob Chemother ,2002,44 (7) : 1778. 被引量：1
